Extracellular vesicles as molecular messengers
Extracellular vesicles (EVs) serve as critical biological couriers, transporting proteins, lipids, and genetic material between cells to maintain tissue repair and immune regulation. A review published September 30, 2026, in Volume 13 of Oncoscience, titled “Extracellular vesicles in health, aging and disease,” details how these particles facilitate essential cellular communication. Researchers Ethan Umeris and Igor Kovalchuk of the University of Lethbridge argue that while these vesicles support homeostasis in healthy tissue, their molecular cargo shifts significantly under the pressures of stress and inflammation.
Senescent cells release inflammatory molecules through exosomes
The research highlights a specific role for exosomes—a well-studied subset of extracellular vesicles—in the aging process. Senescent cells, which have ceased dividing, release exosomes loaded with inflammatory molecules and regulatory microRNAs (miRNAs). These particles act on neighboring cells, potentially driving chronic inflammation and hindering the body’s natural ability to repair tissues. The review indicates that these signals may contribute to chronic inflammation, impaired tissue repair and other changes associated with aging.
Tumor-derived vesicles support cancer cell survival
In the context of oncology, extracellular vesicles take on a different role. Tumor-derived exosomes carry molecular payloads that actively support cancer cell survival and manipulate the local environment to favor disease progression. According to the Oncoscience findings, these vesicles assist in immune evasion, the formation of new blood vessels, and the spread of metastasis. They also contribute to treatment resistance, effectively shielding cancerous cells from therapeutic interventions.
Shared molecular markers in aging and cancer
A central takeaway from the Umeris and Kovalchuk review is the overlap between exosomes released by aging cells and those secreted by tumors. Both types of vesicles carry inflammatory signals, stress-related proteins, and genetic material that disrupt normal cellular function. While the biological outcomes differ based on the environment, the shared molecular characteristics suggest that the mechanisms of cellular communication are a common link between aging and cancer development.
Future paths for biomarker and drug development
The clinical potential for these vesicles lies in their role as indicators of cellular health. Because the cargo of an exosome reflects the state of its originating cell, researchers are investigating them as possible biomarkers of aging and disease. The ability of these particles to transport specific biological molecules has sparked interest in using them as vehicles for targeted drug delivery. The authors note that identifying the specific, divergent cargo of senescence-associated and tumor-derived exosomes is essential to designing effective, targeted therapeutic treatments.
Common questions regarding cellular communication
How do extracellular vesicles differ from exosomes?
Extracellular vesicles is the broader category for particles that transport molecular messages between cells. Exosomes are a specific, well-studied type of extracellular vesicle that play a major role in both healthy cellular regulation and disease pathways.
Why do aging cells and cancer cells share similar signaling patterns?
Research indicates that both aging and cancer involve cellular stress and inflammation, leading to the release of similar inflammatory molecules and regulatory microRNAs. These shared signals suggest that the body’s communication pathways are repurposed in both processes, potentially linking age-related decline to cancer progression.
Can these vesicles be used for medical treatments?
Scientists are currently investigating their use in targeted drug delivery due to their natural ability to transport biological material. However, the authors of the Oncoscience review emphasize that significant further research is required to refine these applications for clinical use.
“Thus, it is important to understand both the overlapping and divergent cargo of senescence-associated and tumor-derived exosomes to identify disease-specific biomarkers and to design targeted therapeutic treatments.”